摘要 |
The use of a substance selected from the group consisting of taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis, for manufacturing a pharmaceutical composition for preventing or inhibiting the undesirable side-effects caused to a human or an animal organism by an active ingredient that induces a high level of extracellular GABA or increases GABA receptor activation. |
申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);PICAUD, SERGE;SAHEL, JOSE, ALAIN;FIRAS, JAMMOUL;CORIAT, CAROLINE;SIMONUTTI, MANUEL |
发明人 |
PICAUD, SERGE;SAHEL, JOSE, ALAIN;FIRAS, JAMMOUL;CORIAT, CAROLINE;SIMONUTTI, MANUEL |